H. Miki
Laboratory of Clinical Pharmacy and Clinical Pharmacokinetics, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
J. Morita
Laboratory of Clinical Pharmacy and Clinical Pharmacokinetics, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
R. Kato
Laboratory of Clinical Pharmacy and Clinical Pharmacokinetics, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
Y. Ijiri
Laboratory of Clinical Pharmacy and Clinical Pharmacokinetics, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
K. Tanaka
Laboratory of Clinical Pharmacy and Clinical Pharmacokinetics, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
PDF Fulltext XML References Citation
How to cite this article
H. Miki, J. Morita, R. Kato, Y. Ijiri and K. Tanaka, 2009. Effects of Sedative Agent JM-1232(-) ((-)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-2-phenyl-3,5,6,7-tetrahydrocyclopenta[f]isoindole-1(2H)-one) on the Carotid Arteries of Rats. Journal of Pharmacology and Toxicology, 4: 213-220.
DOI: 10.3923/jpt.2009.213.220
URL: https://scialert.net/abstract/?doi=jpt.2009.213.220
DOI: 10.3923/jpt.2009.213.220
URL: https://scialert.net/abstract/?doi=jpt.2009.213.220